Oculis Holding
OCS
OCS
7 hedge funds and large institutions have $23.2M invested in Oculis Holding in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.11%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PBPIA
1
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
| $17.7M | +$17.7M | +2,381,196 | New |
|
|
NFGH
2
Nan Fung Group Holdings
Kai Tak,
Hong Kong
| $4.84M | +$4.84M | +651,100 | New |
|
|
CLOS
3
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| $472K | +$472K | +65,000 | New |
|
|
HF
4
HRT Financial
New York
| $178K | +$178K | +24,609 | New |
|
5
UBS Group
Zurich,
Switzerland
| $9.01K | +$9.01K | +1,212 | New |
|
|
EC
6
Elequin Capital
New York
| $2.23K | +$2.23K | +300 | New |
|
|
DCM
7
Dupont Capital Management
Wilmington,
Delaware
| $29 | +$29 | +4 | New |
|